F4CL - Fast for Commercial Launch Platform

When your CMC projects approach the final step to commercial approval, you need to consider how to be sure your drugs successfully reach your intended markets. Regulatory agencies have different requirements and timing. Trust in the right partner so you don't need to worry about the markets you are not familiar with. WuXi STA has extensive experience with all CMC activities and project planning for timely global filings. Our dedicated drug product service package - Fast for Commercial Launch (F4CL) - can support your commercial launch in global markets in parallel with speed, capability, experience, reliability and quality. Our service can help you navigate varying regulatory requirements and develop an optimal drug product manufacturing strategy tailored for your molecules.